Lyell Immunopharma, Inc. (LYEL)
12.09
-0.79
(-6.13%)
USD |
NASDAQ |
Sep 10, 14:19
Lyell Immunopharma Market Cap : 282.87M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 301.35M |
| September 08, 2026 | 316.56M |
| September 04, 2026 | 336.21M |
| September 03, 2026 | 335.04M |
| September 02, 2026 | 349.90M |
| September 01, 2026 | 339.84M |
| August 31, 2026 | 335.04M |
| August 28, 2026 | 339.96M |
| August 27, 2026 | 341.83M |
| August 26, 2026 | 346.28M |
| August 25, 2026 | 362.42M |
| August 24, 2026 | 344.87M |
| August 21, 2026 | 363.36M |
| August 20, 2026 | 359.14M |
| August 19, 2026 | 368.74M |
| August 18, 2026 | 369.44M |
| August 17, 2026 | 317.03M |
| August 14, 2026 | 326.39M |
| August 13, 2026 | 321.47M |
| August 12, 2026 | 331.54M |
| August 11, 2026 | 348.15M |
| August 10, 2026 | 335.28M |
| August 07, 2026 | 344.17M |
| August 06, 2026 | 332.47M |
| August 05, 2026 | 314.69M |
| Date | Value |
|---|---|
| August 04, 2026 | 318.20M |
| August 03, 2026 | 300.24M |
| July 31, 2026 | 301.87M |
| July 30, 2026 | 320.07M |
| July 29, 2026 | 302.57M |
| July 28, 2026 | 303.04M |
| July 27, 2026 | 302.34M |
| July 24, 2026 | 294.64M |
| July 23, 2026 | 298.14M |
| July 22, 2026 | 299.54M |
| July 21, 2026 | 305.84M |
| July 20, 2026 | 301.40M |
| July 17, 2026 | 310.73M |
| July 16, 2026 | 324.03M |
| July 15, 2026 | 332.66M |
| July 14, 2026 | 312.60M |
| July 13, 2026 | 334.30M |
| July 10, 2026 | 350.16M |
| July 09, 2026 | 354.82M |
| July 08, 2026 | 359.26M |
| July 07, 2026 | 371.15M |
| July 06, 2026 | 327.53M |
| July 02, 2026 | 327.76M |
| July 01, 2026 | 302.57M |
| June 30, 2026 | 327.76M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.68B |
| Oncolytics Biotech, Inc. | 97.44M |
| Sangamo Therapeutics, Inc. | 64.21M |
| Sarepta Therapeutics, Inc. | 2.143B |
| Anixa Biosciences, Inc. | 93.97M |
Market Cap Related Metrics
| PS Ratio | 9488.34 |
| Price to Book Value | 1.210 |
| Price | 12.09 |
| Earnings Yield | -97.34% |